Atlas Antibodies AB is a privately held Swedish biotechnology company that develops, manufactures and distributes highly validated antibodies, antigens and mass spectrometry protein quantification standards for life science research.
Founded in 2006 in Stockholm and rooted in the Human Protein Atlas project, the company supplies reagents used in oncology, neurology and other fields by academic and industrial researchers worldwide.
It is majority-owned by Patricia Industries, part of Investor AB, and belongs to the Atlas Life Sciences Group, which also includes evitria and HistoCyte Laboratories following acquisitions completed in 2021.
Ready-to-use CHO‑K1 transient expression kit simplifies lab workflows and speeds consistent protein production for early-stage biologics research.
